| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1614120 | F | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) | Leishmania mexicana mexicana | 3,156 | ALA1201862 | assay format | PubChem BioAssays | |
| 2. | ALA1614174 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | Bacillus subtilis | 24,076 | ALA1201862 | assay format | PubChem BioAssays | |
| 3. | ALA1614249 | B | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | Equus caballus | 42,059 | ALA1201862 | single protein format | PubChem BioAssays | |
| 4. | ALA1614529 | F | PUBCHEM_BIOASSAY: Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors. (Class of assay: confirmatory) [Related pubchem assays: 1022 (Primary screen preceding this dose-response assay.)] | Homo sapiens | 1,105 | ALA1201862 | assay format | PubChem BioAssays | |
| 5. | ALA1614257 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | Homo sapiens | 37,649 | ALA1201862 | assay format | PubChem BioAssays | |
| 6. | ALA1614280 | F | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | Homo sapiens | 13,811 | ALA1201862 | assay format | PubChem BioAssays | |
| 7. | ALA1614531 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) | Homo sapiens | 9,451 | ALA1201862 | assay format | PubChem BioAssays | |
| 8. | ALA1613829 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))] | Homo sapiens | 4,515 | ALA1201862 | assay format | PubChem BioAssays | |
| 9. | ALA1614067 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom's syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM))] | Homo sapiens | 2,514 | ALA1201862 | assay format | PubChem BioAssays | |
| 10. | ALA1614079 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | Homo sapiens | 22,998 | ALA1201862 | assay format | PubChem BioAssays | |
| 11. | ALA1614087 | F | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | Mus musculus | 51,950 | ALA1201862 | assay format | PubChem BioAssays | |
| 12. | ALA1614146 | F | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) | Homo sapiens | 31,975 | ALA1201862 | assay format | PubChem BioAssays | |
| 13. | ALA1614285 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) [Related pubchem assays: 1379 ] | Leishmania mexicana mexicana | 3,156 | ALA1201862 | assay format | PubChem BioAssays | |
| 14. | ALA1614421 | B | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | Homo sapiens | 49,165 | ALA1201862 | single protein format | PubChem BioAssays | |
| 15. | ALA1613836 | F | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) | Homo sapiens | 31,975 | ALA1201862 | assay format | PubChem BioAssays | |
| 16. | ALA1613838 | F | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | Homo sapiens | 21,944 | ALA1201862 | assay format | PubChem BioAssays | |
| 17. | ALA1738023 | F | PUBCHEM_BIOASSAY: Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488970] | 56 | ALA1201862 | assay format | PubChem BioAssays | ||
| 18. | ALA1738588 | F | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | Homo sapiens | 94,040 | ALA1201862 | assay format | PubChem BioAssays | |
| 19. | ALA1737902 | F | PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355] | 75,513 | ALA1201862 | assay format | PubChem BioAssays | ||
| 20. | ALA1737991 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | Homo sapiens | 51,376 | ALA1201862 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!